CVA Family Office LLC Acquires 3,788 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CVA Family Office LLC grew its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1,079.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,139 shares of the pharmacy operator’s stock after acquiring an additional 3,788 shares during the quarter. CVA Family Office LLC’s holdings in Walgreens Boots Alliance were worth $50,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Blue Trust Inc. lifted its position in shares of Walgreens Boots Alliance by 115.7% in the 4th quarter. Blue Trust Inc. now owns 1,775 shares of the pharmacy operator’s stock worth $46,000 after acquiring an additional 952 shares during the period. Ballentine Partners LLC acquired a new stake in Walgreens Boots Alliance during the fourth quarter worth $201,000. International Assets Investment Management LLC boosted its stake in Walgreens Boots Alliance by 1,985.1% during the fourth quarter. International Assets Investment Management LLC now owns 889,546 shares of the pharmacy operator’s stock worth $23,226,000 after buying an additional 846,884 shares in the last quarter. Arkadios Wealth Advisors increased its holdings in Walgreens Boots Alliance by 5.4% in the 4th quarter. Arkadios Wealth Advisors now owns 23,486 shares of the pharmacy operator’s stock valued at $613,000 after buying an additional 1,207 shares during the period. Finally, Prime Capital Investment Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 20.3% in the 4th quarter. Prime Capital Investment Advisors LLC now owns 17,435 shares of the pharmacy operator’s stock valued at $455,000 after buying an additional 2,945 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 1.2 %

WBA traded down $0.13 during trading on Wednesday, reaching $10.78. 14,101,852 shares of the company’s stock were exchanged, compared to its average volume of 15,745,724. The company’s fifty day moving average price is $13.27 and its 200-day moving average price is $17.56. The firm has a market capitalization of $9.31 billion, a PE ratio of -1.60, a P/E/G ratio of 0.80 and a beta of 0.72. Walgreens Boots Alliance, Inc. has a fifty-two week low of $10.62 and a fifty-two week high of $29.85. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $36.40 billion during the quarter, compared to the consensus estimate of $35.94 billion. During the same quarter in the prior year, the company posted $1.00 EPS. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. As a group, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 9.28%. Walgreens Boots Alliance’s dividend payout ratio is -14.84%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on WBA. Barclays lowered their price objective on Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a research note on Tuesday, July 23rd. Truist Financial dropped their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a research note on Friday, June 28th. UBS Group dropped their target price on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research report on Wednesday, July 3rd. JPMorgan Chase & Co. reduced their price target on shares of Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating on the stock in a research report on Monday, July 1st. Finally, TD Cowen dropped their price objective on shares of Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating for the company in a report on Monday, July 1st. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus price target of $16.86.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.